Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project.

Keywords

Medicine, Discontinuation, Lower urinary tract symptoms, Internal medicine, Urination

References

• Postmarketing Surveillance Based on Electronic Patient Records: The IPCI ProjectJohan van der Lei, Mees Mosseveld, M A van Wijk — 1999
• Health and Health care in the NetherlandsC. de Putter, Jan Dekker — 2002
• Medical management of benign prostatic hyperplasia.Andrew Chacon, Manoj Monga — 1999
• Replicating the chronic disease score (CDS) from automated pharmacy data.Richard E. Johnson, Mark C. Hornbrook, Gregory A. Nichols — 1994
• The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.Paul Abrams, Linda Cardozo, Magnus Fall — 2003
• Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction – What’s the Long-Term Effectiveness of Medical Therapies?Martin C. Michel, Μ. Goepel — 2001
• Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction – Triumph: Design and ImplementationChristopher R. Chapple — 2001
• Management of Symptomatic BPH in France: Who Is Treated and How?B. Lukacs — 1999
• International primary care classifications: the effect of fifteen years of evolution.H Lamberts, M Wood, I. M. Hofmans-okkes — 1992
• Management of Symptomatic BPH in the US: Who Is Treated and How?Reginald C. Bruskewitz — 1999
• How Do Symptoms Indicative of BPH Progress in Real Life Practice? The UK ExperienceGary M. Clifford, John Logie, Richard Farmer — 2000
• Management of Symptomatic BPH in the UK: Who Is Treated and How?Tom McNicholas — 1999
• Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: What Are the Current Practice Patterns?Tom McNicholas — 2001
• Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia.Martin C. Michel, LUDWIG MEHLBURGER, Helmut Schumacher — 2000
• A chronic disease score from automated pharmacy data.Michael Von Korff, Edward H. Wagner, Kathleen Saunders — 1992
• The Introduction of Computer-based Patient Records in the NetherlandsJohan van der Lei, Joop S. Duisterhout, Henk P. Westerhof — 1993
• Who Should Be Treated and How? Evidence-Based Medicine in Symptomatic BPHMark Speakman — 1999
• The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.Claus G. Roehrborn, Joseph E. Oesterling, Stephen M. Auerbach — 1996
• Initial Choices and Final Outcomes in Lower Urinary Tract SymptomsMark Speakman — 2001
• Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: What Is the Available Evidence for Rational Management?Mark Speakman — 2001

Cited by

• Pathophysiologie und Therapie der benignen Prostata-HyperplasieNatalie Sampson, Stephan Madersbacher, Peter Berger — 2008
• Reasons for prescription change of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.吕建钦, 赵小松 — 2014
• Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12‐week Placebo‐controlled Dose‐finding Study with a 42‐week Open‐label ExtensionMasayuki Takeda, Osamu Nishizawa, Takeshi Imaoka — 2012
• Adherence to 5-alpha reductase inhibitor therapy for benign prostatic hyperplasia: clinical and economic outcomes.Stephen K. Gruschkus, Sara Poston, Michael Eaddy — 2012
• UroLift system for relief of prostate obstruction under local anesthesia.Jack Barkin, Jonathan Giddens, Peter Incze — 2012
• Dosage and duration of medication for men with lower urinary tract symptoms: two questions without definitive answersFrançois Desgrandchamps, P. Mongiat-Artus — 2006
• Automatic background extraction for Prostate Biopsy imagesRecep Demırcı, H. Güçlü Yavuzcan, Ozan Incetas — 2012
• [Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study].François Lacoin, R Fourcade, Morgan Rouprêt — 2013
• Three year results of the prostatic urethral L.I.F.T. study.Claus G. Roehrborn, Daniel B. Rukstalis, Jack Barkin — 2015
• New intraprostatic injectables and prostatic urethral lift for male LUTSGiuseppe Magistro, Christian G. Stief, Christian Gratzke — 2015
• The Role of Intraprostatic Inflammation in the Acute Urinary RetentionSeyed Alaeddin Asgari, Mohaddeseh Mohammadi — 2011
• Natural course of lower urinary tract symptoms following discontinuation of alpha‐1‐adrenergic blockers in patients with benign prostatic hyperplasiaTeruhiko Yokoyama, Toyohiko Watanabe, Takashi Saika — 2007
• Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.Kevin T. McVary, Steven Gange, Neal D. Shore — 2014
• Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the LiteratureAlessandro Larcher, L. Broglia, Giovanni Lughezzani — 2013
• Improving therapeutic outcomes in BPH through diagnosis, treatment and patient compliance.Joel DeCastro, Brian Stone — 2008
• Significance of Intraprostatic Inflammation in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic HyperplasiaWonho Jung, Mi Sun Choi, Hyuk Soo Chang — 2009
• The long-term outcome of medical therapy for BPH.Stephan Madersbacher, Martin Marszalek, Jakob Lackner — 2007
• The Long-Term Cost Effectiveness of Treatments for Benign Prostatic HyperplasiaRachael L. DiSantostefano, Andrea K. Biddle, John P. Lavelle — 2012
• Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.Michael B. Nichol, Tara K. Knight, Joanne Wu — 2009
• The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.Claus G. Roehrborn, Steven Gange, Neal D. Shore — 2013

Related papers

• Types Research of Discontinuation of a CrimeZhang Ping — 2007
• Current and future applications of SPECT in clinical psychiatry.J C Ballenger — 1992
• Bladder instability and abnormal micturition pattern in rats with infravesical outflow obstructionAnna Malmgren — 1987
• [Discontinuation of chronic treatment with lithium salts].Leonardo Tondo, N Rudas — 1991
• Contraceptive discontinuation and switching in urban Istanbul region in TurkeySebahat Kurutas, Ryoko Sato, Sarah Huber‐Krum — 2021
• Management of antiepileptic drugs following epilepsy surgery: a meta-analysis.Lady Diana Ladino, Lizbeth Hernández‐Ronquillo, José Francisco Téllez‐Zenteno — 2014
• Ezogabine skin discoloration is reversible after discontinuationSally Mathias, Bassel Abou‐Khalil — 2017
• Lower urinary tract symptoms and toileting behaviors in Turkish adult womenŞeyda Toprak Çelenay, Elif Sena Düşgün, Yasemin Karaaslan — 2023